Form 8-K HEALTHEQUITY, INC. For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
HealthEquity, Inc (HQY) PT Raised to $97 at BofA Securities
March 20, 2024 4:41 AM EDTBofA Securities analyst Allen Lutz raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $97.00 (from $93.00) while maintaining a Buy rating.
The analyst comments "HealthEquity reported a strong quarter, with strong expense management in Technology & Development the largest upside driver versus our model. FY25 revenue and EBITDA guidance was in line... More
HealthEquity, Inc (HQY) PT Raised to $110 at BTIG
March 20, 2024 4:11 AM EDTBTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 (from $100.00) while maintaining a Buy rating.
The analyst comments "On Tuesday, 3/19/24 AMC, HQY reported excellent F4Q:24 results. Total revenue of $262.4M +12% y/y exceeded BTIG / consensus estimates of $260.7M / $258.7M and adjusted EBITDA of $98.8M +34% y/y also exceeded BTIG / consensus estimates of $98M / $91.5M. HQY re-affirmed revenue guidance for... More
